Angiogenic activity of nicotinic acetylcholine receptors: Implications in tobacco-related vascular diseases

Pharmacology and Therapeutics

Volumn 121, Issue 2, 2009, Pages 205-223

  Egleton, Richard D ^a   Brown, Kathleen C ^a   Dasgupta, Piyali ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7nAChR; Angiogenesis; Cancer; Cardiovascular blindness; Nicotinic receptor

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ANGIOGENESIS; CIGARETTE SMOKING; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TOBACCO; VASCULAR DISEASE;

ANIMALS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SMOKING; TOBACCO;

EID: 59849107221     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.10.007     Document Type: Review

References (199)

1. Abbruscato T.J., Lopez S.P., Mark K.S., Hawkins B.T., and Davis T.P. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 91 (2002) 2525-2538
2. Abbruscato T.J., Lopez S.P., Roder K., and Paulson J.R. Regulation of blood-brain barrier Na,K,2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. J Pharmacol Exp Ther 310 (2004) 459-468
3. ACS. Cancer facts and figures (2002), American Cancer Society
4. Adamopoulos D., van de Borne P., and Argacha J.F. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol 35 (2008) 458-463
5. Aicher A., Heeschen C., Mohaupt M., Cooke J.P., Zeiher A.M., and Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107 (2003) 604-611
6. Albaugh G., Bellavance E., Strande L., Heinburger S., Hewitt C.W., and Alexander J.B. Nicotine induces mononuclear leukocyte adhesion and expression of adhesion molecules, VCAM and ICAM, in endothelial cells in vitro. Ann Vasc Surg 18 (2004) 302-307
7. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40 (2008) 616-622
8. Andreoli C.M., and Miller J.W. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18 (2007) 502-508
9. Arredondo J., Chernyavsky A., and Grando S. The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells. J Cancer Res Clin Oncol 132 (2006) 653-663
10. Arredondo J., Chernyavsky A.I., and Grando S.A. Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther 5 (2006) 511-517
11. Arredondo J., Chernyavsky A.I., Jolkovsky D.L., Webber R.J., and Grando S.A. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. J Cell Physiol 208 (2006) 238-245
12. Arredondo J., Chernyavsky A.I., Webber R.J., and Grando S.A. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol 125 (2005) 1236-1241
13. Augustin H.G. Antiangiogenic tumour therapy: Will it work?. Trends Pharmacol Sci 19 (1998) 216-222
14. Augustin H.G. Tubes, branches, and pillars: The many ways of forming a new vasculature. Circ Res 89 (2001) 645-647
15. Avogaro A., and Fadini G.P. The Janus face of nicotinic angiogenesis. J Am Coll Cardiol 48 (2006) 2561-2563
16. Bailey T.L., Rivara C.B., Rocher A.B., and Hof P.R. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26 (2004) 573-578
17. Benowitz N.L. Systemic absorption and effects of nicotine from smokeless tobacco. Adv Dent Res 11 (1997) 336-341
18. Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 (2003) 401-410
19. Bloomgarden Z.T. Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm 64 (2007) S8-14
20. Bordel R., Laschke M.W., Menger M.D., and Vollmar B. Nicotine does not affect vascularization but inhibits growth of freely transplanted ovarian follicles by inducing granulosa cell apoptosis. Hum Reprod 21 (2006) 610-617
21. Bouras C., Kovari E., Herrmann F.R., Rivara C.B., Bailey T.L., von Gunten A., et al. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol 65 (2006) 235-244
22. Bschleipfer T., Schukowski K., Weidner W., Grando S.A., Schwantes U., Kummer W., et al. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80 (2007) 2303-2307
23. Cao Y. Molecular mechanisms and therapeutic development of angiogenesis inhibitors. Adv Cancer Res 100 (2008) 113-131
24. Carlisle D.L., Hopkins T.M., Gaither-Davis A., Silhanek M.J., Luketich J.D., Christie N.A., et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res 5 (2004) 27
25. Cattaneo M.G., Codignola A., Vicentini L.M., Clementi F., and Sher E. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 53 (1993) 5566-5568
26. Cattaneo M.G., D'Atri F., and Vicentini L.M. Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem J 328 Pt 2 (1997) 499-503
27. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7 (2001) 425-429
28. Charpantier E., Wiesner A., Huh K.H., Ogier R., Hoda J.C., Allaman G., et al. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci 25 (2005) 9836-9849
29. Conklin B.S., Zhao W., Zhong D., and Chen C. Nicotine and cotinine upregulate vascular endothelial growth factor expression in endothelial cells. American Journal of Pathology 160 (2002) 413-419
30. Conti-Fine B.M., Navaneetham D., Lei S., and Maus A.D. Neuronal nicotinic receptors in non-neuronal cells: New mediators of tobacco toxicity?. Eur J Pharmacol 393 (2000) 279-294
31. Cook J.P., and Bitterman H. Nicotine and angiogenesis: A new paradigm for tobacco-related diseases. Ann Med 36 (2004) 33-40
32. Cooke J.P. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci 80 (2007) 2347-2351
33. Cooke J.P., and Bitterman H. Nicotine and angiogenesis: A new paradigm for tobacco-related diseases. Ann Med 36 (2004) 33-40
34. Crawford Y., and Ferrara N. VEGF inhibition: Insights from preclinical and clinical studies. Cell Tissue Res (2008) [Electronic publication ahead of print]
35. Cucina A., Corvino V., Sapienza P., Borrelli V., Lucarelli M., Scarpa S., et al. Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem Biophys Res Commun 257 (1999) 306-312
36. Cucina A., Sapienza P., Borrelli V., Corvino V., Foresi G., Randone B., et al. Nicotine reorganizes cytoskeleton of vascular endothelial cell through platelet-derived growth factor BB. J Surg Res 92 (2000) 233-238
37. Cucina A., Sapienza P., Corvino V., Borrelli V., Mariani V., Randone B., et al. Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1. Surgery 127 (2000) 316-322
38. Cucina A., Sapienza P., Corvino V., Borrelli V., Randone B., Santoro-D'Angelo L., et al. Nicotine induces platelet-derived growth factor release and cytoskeletal alteration in aortic smooth muscle cells. Surgery 127 (2000) 72-78
39. Cunningham J.M., Lennon V.A., Lambert E.H., and Scheithauer B. Acetylcholine receptors in small cell carcinomas. J Neurochem 45 (1985) 159-167
40. Dasgupta P., Betts V., Rastogi S., Joshi B., Morris M., Brennan B., et al. Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery (2004)
41. Dasgupta P., Sun J., Wang S., Fusaro G., Betts V., Padmanabhan J., et al. Disruption of the Rb-Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol 24 (2004) 9527-9541
42. Dasgupta P., and Chellappan S.P. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5 (2006) 2324-2328
43. Dasgupta P., Kinkade R., Joshi B., Decook C., Haura E., and Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A 103 (2006) 6332-6337
44. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M., Haura E., et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 116 (2006) 2208-2217
45. de Jonge W.J., and Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151 (2007) 915-929
46. De Simone R., Ajmone-Cat M.A., Carnevale D., and Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2 (2005) 4
47. Desai B.S., Monahan A.J., Carvey P.M., and Hendey B. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy. Cell Transplant 16 (2007) 285-299
48. Doura M.B., Gold A.B., Keller A.B., and Perry D.C. Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215 (2008) 40-52
49. Eglen R.M. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol 26 (2006) 219-233
50. Evans J.R. Risk factors for age-related macular degeneration. Prog Retin Eye Res 20 (2001) 227-253
51. Feret A., Steinweg S., Griffin H.C., and Glover S. Macular degeneration: Types, causes, and possible interventions. Geriatr Nurs 28 (2007) 387-392
52. Folkman J. Angiogenesis inhibitors: A new class of drugs. Cancer Biol Ther 2 (2003) S127-133
53. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 3 (2003) 643-651
54. Folkman J. Angiogenesis: An organizing principle for drug discovery?. Nat Rev Drug Discov 6 (2007) 273-286
55. Fucile S. Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35 (2004) 1-8
56. Fujii T., Mori Y., Tominaga T., Hayasaka I., and Kawashima K. Maintenance of constant blood acetylcholine content before and after feeding in young chimpanzees. Neurosci Lett 227 (1997) 21-24
57. Fujii T., Yamada S., Yamaguchi N., Fujimoto K., Suzuki T., and Kawashima K. Species differences in the concentration of acetylcholine, a neurotransmitter, in whole blood and plasma. Neurosci Lett 201 (1995) 207-210
58. Gallowitsch-Puerta M., and Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 80 (2007) 2325-2329
59. Gahring L.C., Persiyanov K., and Rogers S.W. Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain. J Comp Neurol 468 (2004) 322-333
60. Gahring L.C., and Rogers S.W. Nicotinic acetylcholine receptor expression in the hippocampus of 27 mouse strains reveals novel inhibitory circuitry. Hippocampus (2008)
61. Girod R., Crabtree G., Ernstrom G., Ramirez-Latorre J., McGehee D., Turner J., et al. Heteromeric complexes of alpha 5 and/or alpha 7 subunits. Effects of calcium and potential role in nicotine-induced presynaptic facilitation. Ann N Y Acad Sci 868 (1999) 578-590
62. Glowatzki E., and Fuchs P.A. Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. Science 288 (2000) 2366-2368
63. Gotti C., and Clementi F. Neuronal nicotinic receptors: From structure to pathology. Prog Neurobiol 74 (2004) 363-396
64. Grando S.A. Receptor-mediated action of nicotine in human skin. Int J Dermatol 40 (2001) 691-693
65. Grando S.A. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J Pharmacol Sci 106 (2008) 174-179
66. Grieshaber M.C., Mozaffarieh M., and Flammer J. What is the link between vascular dysregulation and glaucoma?. Surv Ophthalmol 52 (2007) S144-154 Suppl 2
67. Griffioen A.W., and Molema G. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52 (2000) 237-268
68. Gritz E.R., Baer-Weiss V., Benowitz N.L., Van Vunakis H., and Jarvik M.E. Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther 30 (1981) 201-209
69. Grozio A., Catassi A., Cavalieri Z., Paleari L., Cesario A., and Russo P. Nicotine, lung and cancer. Anticancer Agents Med Chem 7 (2007) 461-466
70. Hanisch U.K., and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10 (2007) 1387-1394
71. Hawkins B.T., Abbruscato T.J., Egleton R.D., Brown R.C., Huber J.D., Campos C.R., et al. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 1027 (2004) 48-58
72. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57 (2005) 173-185
73. Hawkins B.T., Egleton R.D., and Davis T.P. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am J Physiol Heart Circ Physiol 289 (2005) H212-219
74. Hecht S.S. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 3 (2002) 461-469
75. Heeschen C., Jang J.J., Weis M., Pathak A., Kaji S., Hu R.S., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Medicine 7 (2001) 833-839
76. Heeschen C., Weis M., Aicher A., Dimmler S., and Cooke J.P. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110 (2002) 527-536
77. Heeschen C., Weis M., and Cooke J.P. Nicotine promotes arteriogenesis. J Am Coll Cardiol 41 (2003) 489-496
78. Heeschen C., Chang E., Aicher A., and Cooke J.P. Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J Am Coll Cardiol 48 (2006) 2553-2560
79. Hosli L., Hosli E., Della Briotta G., Quadri L., and Heuss L. Action of acetylcholine, muscarine, nicotine and antagonists on the membrane potential of astrocytes in cultured rat brainstem and spinal cord. Neurosci Lett 92 (1988) 165-170
80. Hou H.Y., Wang Y.S., Xu J.F., and Wang B.R. Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice. Exp Eye Res 86 (2008) 983-990
81. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452 (2008) 633-637
82. Itier V., and Bertrand D. Neuronal nicotinic receptors: From protein structure to function. FEBS Lett 504 (2001) 118-125
83. Jacobi J., Jang J.J., Sundram U., Dayoub H., Fajardo L.F., and Cooke J.P. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 161 (2002) 97-104
84. Jarzynka M.J., Guo P., Bar-Joseph I., Hu B., and Cheng S.Y. Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol 28 (2006) 337-344
85. Jain R.K. Clearing the smoke on nicotine and angiogenesis. Nat Med 7 (2001) 775-777
86. Jain R.K., Finn A.V., Kolodgie F.D., Gold H.K., and Virmani R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med 4 (2007) 491-502
87. Jull B.A., Plummer H.K., and Schuller H.M. Nicotinic receptor-mediated activation by tobacco-specific nitrosamine NNK of a Raf-1/MAPkinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma and pulmonary neuroendocrine cells. J Cancer Res clin Oncol 127 (2001) 707-717
88. Kanda Y., and Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells. Life Sci 80 (2007) 1409-1414
89. Kawashima K., Oohata H., Fujimoto K., and Suzuki T. Plasma concentration of acetylcholine in young women. Neurosci Lett 80 (1987) 339-342
90. Quesada A.R., Medina M.A., and Alba E. Playing only one instrument may be not enough: Limitations and future of the antiangiogenic treatment of cancer. Bioessays 29 (2007) 1159-1168
91. Kawashima K., Watanabe N., Oohata H., Fujimoto K., Suzuki T., Ishizaki Y., et al. Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci Lett 119 (1990) 156-158
92. Kawashima K., Yoshikawa K., Fujii Y.X., Moriwaki Y., and Misawa H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 80 (2007) 2314-2319
93. Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Yates J.R., Bradley M., et al. Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90 (2006) 75-80
94. Kinkade R., Dasgupta P., Carie A., Pernazza D., Carless M., Pillai S., et al. A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Res 68 (2008) 3810-3818
95. Kiuchi K., Matsuoka M., Wu J.C., Lima E.S.R., Kengatharan M., Verghese M., et al. Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci 49 (2008) 1705-1711
96. Krady J.K., Basu A., Allen C.M., Xu Y., LaNoue K.F., Gardner T.W., et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54 (2005) 1559-1565
97. Kubrusly R.C., da Cunha M.C., Reis R.A., Soares H., Ventura A.L., Kurtenbach E., et al. Expression of functional receptors and transmitter enzymes in cultured Muller cells. Brain Res 1038 (2005) 141-149
98. Kuiper E.J., Witmer A.N., Klaassen I., Oliver N., Goldschmeding R., and Schlingemann R.O. Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol 88 (2004) 1082-1087
99. Kumar P., and Meizel S. Nicotinic acetylcholine receptor subunits and associated proteins in human sperm. J Biol Chem 280 (2005) 25928-25935
100. Lam D.C., Girard L., Ramirez R., Chau W.S., Suen W.S., Sheridan S., et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res 67 (2007) 4638-4647
101. La Thangue N.B. The yin and yang of E2F-1: balancing life and death. Nat Cell Biol 5 (2003) 587-589
102. Lefkowitz R.J., Rajagopal K., and Whalen E.J. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 24 (2006) 643-652
103. Li X.W., and Wang H. Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization. Life Sci 78 (2006) 1863-1870
104. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 15 (1997) 193-222
105. Lindstrom J.M. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 998 (2003) 41-52
106. Lukas R.J. Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites. J Pharmacol Exp Ther 253 (1990) 51-57
107. Michels S., Schmidt-Erfurth U., and Rosenfeld P.J. Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs 15 (2006) 779-793
108. Minna J.D. The molecular biology of lung cancer pathogenesis. Chest 103 (1993) 449S-456S
109. Minna J.D. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 111 (2003) 31-33
110. Mohamed A.S., and Swope S.L. Phosphorylation and cytoskeletal anchoring of the acetylcholine receptor by Src class protein-tyrosine kinases. Activation by rapsyn. J Biol Chem 274 (1999) 20529-20539
111. Moon J.H., Kim S.Y., Lee H.G., Kim S.U., and Lee Y.B. Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia. Exp Mol Med 40 (2008) 11-18
112. Morimoto N., Takemoto S., Kawazoe T., and Suzuki S. Nicotine at a low concentration promotes wound healing. J Surg Res 145 (2008) 199-204
113. Moriwaki Y., Yoshikawa K., Fukuda H., Fujii Y.X., Misawa H., and Kawashima K. Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Life Sci 80 (2007) 2365-2368
114. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., and Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99 (1999) 1726-1732
115. Moulton K.S., Vakili K., Zurakowski D., Soliman M., Butterfield C., Sylvin E., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100 (2003) 4736-4741
116. Mousa S., and Mousa S.A. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J Cellular Biochem 97 (2006) 1370-1378
117. Natori T., Sata M., Washida M., Hirata Y., Nagai R., and Makuuchi M. Nicotine enhances neovascularization and promotes tumor growth. Mol Cells 16 (2003) 143-146
118. Nevins J.R. The Rb/E2F pathway and cancer. Hum Mol Genet 10 (2001) 699-703
119. Ng M.K., Wu J., Chang E., Wang B.Y., Katzenberg-Clark R., Ishii-Watabe A., et al. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 27 (2007) 106-112
120. Oh Y.T., Lee J.Y., Yoon H., Lee E.H., Baik H.H., Kim S.S., et al. Lipopolysaccharide induces hypoxia-inducible factor-1 alpha mRNA expression and activation via NADPH oxidase and Sp1-dependent pathway in BV2 murine microglial cells. Neurosci Lett 431 (2008) 155-160
121. Okoli C.T., Kelly T., and Hahn E.J. Secondhand smoke and nicotine exposure: a brief review. Addict Behav 32 (2007) 1977-1988
122. Patti L., Raiteri L., Grilli M., Zappettini S., Bonanno G., and Marchi M. Evidence that alpha7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes. Neurochem Int 51 (2007) 1-7
123. Patton A.M., Kassis J., Doong H., and Kohn E.C. Calcium as a molecular target in angiogenesis. Curr Pharm Des 9 (2003) 543-551
124. Paulson J.R., Roder K.E., McAfee G., Allen D.D., Van der Schyf C.J., and Abbruscato T.J. Tobacco smoke chemicals attenuate brain-to-blood potassium transport mediated by the Na,K,2Cl-cotransporter during hypoxia-reoxygenation. J Pharmacol Exp Ther 316 (2006) 248-254
125. Perry D.C., Mao D., Gold A.B., McIntosh J.M., Pezzullo J.C., and Kellar K.J. Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322 (2007) 306-315
126. Picciotto M.R., and Zoli M. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front Biosci 13 (2008) 492-504
127. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (1992) 845-848
128. Pogocki D., Ruman T., Danilczuk M., Danilczuk M., Celuch M., and Walajtys-Rode E. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders. Eur J Pharmacol 563 (2007) 18-39
129. Quik M., Bordia T., and O'Leary K. Nicotinic receptors as CNS targets for Parkinson's disease. Biochem Pharmacol 74 (2007) 1224-1234
130. Rogers S.W., Gregori N.Z., Carlson N., Gahring L.C., and Noble M. Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia 33 (2001) 306-313
131. Ruegg C., Hasmim M., Lejeune F.J., and Alghisi G.C. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochim Biophys Acta 1765 (2006) 155-177
132. Ruixing Y., Qi B., Tangwei L., and Jiaquan L. Effects of nicotine on angiogenesis and restenosis in a rabbit model. Cardiology 107 (2007) 122-131
133. Rungger-Brandle E., Dosso A.A., and Leuenberger P.M. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41 (2000) 1971-1980
134. Russell M.A., Jarvis M.J., Devitt G., and Feyerabend C. Nicotine intake by snuff users. Br Med J (Clin Res Ed) 283 (1981) 814-817
135. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201 (2005) 1113-1123
136. Sastre M., Klockgether T., and Heneka M.T. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24 (2006) 167-176
137. Sastry B.V., Chance M.B., Singh G., Horn J.L., and Janson V.E. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology 50 (1995) 128-136
138. Sastry B.V., and Hemontolor M.E. Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function. J Ocul Pharmacol Ther 14 (1998) 447-458
139. Schuller H.M. Nitrosamines as nicotinic receptor ligands. Life Sci 80 (2007) 2274-2280
140. Schuller H.M., Jull B.A., Sheppard B.J., and Plummer H.K. Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol 393 (2000) 265-277
141. Schuller H.M., Plummer III H.K., and Jull B.A. Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat Rec 270A (2003) 51-58
142. Sekido Y., Fong K.M., and Minna J.D. Molecular genetics of lung cancer. Annu Rev Med 54 (2003) 73-87
143. Sharma G., and Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 98 (2001) 4148-4153
144. Sharma G., and Vijayaraghavan S. Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 53 (2002) 524-534
145. Sheppard B.J., Williams M., Plummer H.K., and Schuller H.M. Activation of voltage-operated Ca2+-channels in human small cell lung carcinoma by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Int J Oncol 16 (2000) 513-518
146. Sher E., Codignola A., Passafaro M., Tarroni P., Magnelli V., Carbone E., et al. Nicotinic receptors and calcium channels in small cell lung carcinoma. Functional role, modulation, and autoimmunity. Ann N Y Acad Sci 841 (1998) 606-624
147. Shin V.Y., Wu W.K., Chu K.M., Wong H.P., Lam E.K., Tai E.K., et al. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res 3 (2005) 607-615
148. Shin V.Y., Wu W.K., Ye Y.N., So W.H., Koo M.W., Liu E.S., et al. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis 25 (2004) 2487-2495
149. Shin V.Y., Wu W.K., Chu K.M., Koo M.W., Wong H.P., and Lam E.K. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci 96 (2007) 21-29
150. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89 (2004) 337-343
151. Simo R., Carrasco E., Garcia-Ramirez M., and Hernandez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2 (2006) 71-98
152. Song P., Sekhon H.S., Jia Y., Keller J.A., Blusztajn J.K., Mark G.P., et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res 63 (2003) 214-221
153. Song P., Sekhon H.S., Proskocil B., Blusztajn J.K., Mark G.P., and Spindel E.R. Synthesis of acetylcholine by lung cancer. Life Sci 72 (2003) 2159-2168
154. Song P., and Spindel E.R. Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy. J Pharmacol Sci 106 (2008) 180-185
155. Stevaux O., and Dyson N.J. A revised picture of E2f Transcriptional regulation and Rb funtion. Current Opinion in Cell Biology 14 (2002) 684-691
156. Sugimoto A., Masuda H., Eguchi M., Iwaguro H., Tanabe T., and Asahara T. Nicotine enlivenment of blood flow recovery following endothelial progenitor cell transplantation into ischemic hindlimb. Stem Cells Dev 16 (2007) 649-656
157. Suner I.J., Espinosa-Heidmann D.G., Marin-Castano M.E., Hernandez E.P., Pereira-Simon S., and Cousins S.W. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45 (2004) 311-317
158. Suzuki T., Hide I., Matsubara A., Hama C., Harada K., Miyano K., et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res 83 (2006) 1461-1470
159. Swope S.L., Qu Z., and Huganir R.L. Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinases. Ann N Y Acad Sci 757 (1995) 197-214
160. Tata A.M. Muscarinic acetylcholine receptors: new potential therapeutic targets in antinociception and in cancer therapy. Recent Patents CNS Drug Discov 3 (2008) 94-103
161. Taylor R.G., Woodman G., and Clarke S.W. Plasma nicotine concentration and the white blood cell count in smokers. Thorax 41 (1986) 407-408
162. Teaktong T., Graham A.J., Court J.A., Perry R.H., Jaros E., Johnson M., et al. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci 225 (2004) 39-49
163. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 (2008) 638-642
164. Titof P.K., Elgayyar M., Schuller H.M., Barnhill M., and Andrews R. 4- (Methylnitrosoamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis in endothelial cells. Am J Physiol Heart Circ Physiol 281 (2001) H1946-H1954
165. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
166. Trombino S., Bisio A., Catassi A., Cesario A., Falugi C., and Russo P. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: Possibility of new therapeutic strategies. Curr Med Chem Anticancer Agents 4 (2004) 535-542
167. Trombino S., Cesario A., Margaritora S., Granone P., Motta G., Falugi C., et al. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res 64 (2004) 135-145
168. Ueno H., Pradhan S., Schlessel D., Hirasawa H., and Sumpio B.E. Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1. Cardiovasc Toxicol 6 (2006) 39-50
169. Uranishi R., Baev N.I., Ng P.Y., Kim J.H., and Awad I.A. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48 (2001) 359-367 discussion 367-358
170. Valenca S.S., de Souza da Fonseca A., da Hora K., Santos R., and Porto L.C. Lung morphometry and MMP-12 expression in rats treated with intraperitoneal nicotine. Exp Toxicol Pathol 55 (2004) 393-400
171. van Zandwijk N., and Hirsch F.R. Chemoprevention of lung cancer: current status and future prospects. Lung Cancer 42 Suppl 1 (2003) S71-79
172. Vander Ark W., DiNardo L.J., and Oliver D.S. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope 107 (1997) 888-892
173. Villablanca A.C. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84 (1998) 2089-2098
174. Wang L., McComb J.G., Weiss M.H., McDonough A.A., and Zlokovic B.V. Nicotine downregulates alpha 2 isoform of Na,K-ATPase at the blood-brain barrier and brain in rats. Biochem Biophys Res Commun 199 (1994) 1422-1427
175. Wang S., Ghosh R.N., and Chellappan S.P. Raf-1 physically interacts with Rb and regulates its function: A link between mitogenic signaling and cell cycle regulation. Mol Cell Biol 18 (1998) 7487-7498
176. Wang H., Shi H., Zhang L., Pourrier M., Yang B., Nattel S., et al. Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current. Circulation 102 (2000) 1165-1171
177. Wang X., Zhu J., Chen J., and Shang Y. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J Clin Pharmacol 44 (2004) 881-889
178. Wang Y., Wang Z., Wang L., Zhou Y., Zhao Y., Liu L., et al. Estrogen down-regulates nicotine-induced adhesion molecule expression via nongenomic signal pathway in endothelial cells. Int Immunopharmacol 6 (2006) 892-902
179. Wells A., Huttenlocher A., and Lauffenburger D.A. Calpain proteases in cell adhesion and motility. Int Rev Cytol 245 (2005) 1-16
180. Wessler I., Kirkpatrick C.J., and Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77 (1998) 59-79
181. Wessler I., Kirkpatrick C.J., and Racke K. The cholinergic 'pitfall': Acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26 (1999) 198-205
182. Wessler I.K., and Kirkpatrick C.J. The Non-neuronal cholinergic system: An emerging drug target in the airways. Pulm Pharmacol Ther 14 (2001) 423-434
183. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., Swain S.M., et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111 (2003) 81-90
184. West K.A., Linnoila I.R., Belinsky S.A., Harris C.C., and Dennis P.A. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res 64 (2004) 446-451
185. West R.J., Jarvis M.J., Russell M.A., and Feyerabend C. Plasma nicotine concentrations from repeated doses of nasal nicotine solution. Br J Addict 79 (1984) 443-445
186. Wolburg H., and Lippoldt A. Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul Pharmacol 38 (2002) 323-337
187. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., and Cho C.H. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 97 (2007) 279-287
188. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., and Cho C.H. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 221 (2007) 261-267
189. Xin M., and Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280 (2005) 10781-10789
190. Xiu J., Nordberg A., Zhang J.T., and Guan Z.Z. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochem Int 47 (2005) 281-290
191. Xu L., and Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem 281 (2006) 4457-4466
192. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150 (2007) 963-976
193. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., Luo J.C., and Cho C.H. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 308 (2004) 66-72
194. Yu W.F., Guan Z.Z., Bogdanovic N., and Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Exp Neurol 192 (2005) 215-225
195. Zarghooni S., Wunsch J., Bodenbenner M., Bruggmann D., Grando S.A., Schwantes U., et al. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci 80 (2007) 2308-2313
196. Zeidler R., Albermann K., and Lang S. Nicotine and apoptosis. Apoptosis 12 (2007) 1927-1943
197. Zeng H.Y., Green W.R., and Tso M.O. Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126 (2008) 227-232
198. Zhang Q., Tang X., Zhang Z.F., Velikina R., Shi S., and Le A.D. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 13 (2007) 4686-4694
199. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28 (2005) 202-208